transferrin has been researched along with Familial Nonmedullary Thyroid Cancer in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (76.92) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Kao, YH | 1 |
| C Ferreira, T; Cavaco, BM; Leite, V; Limbert, E; Simões-Pereira, J | 1 |
| Abe, K; Horiuchi, K; Ishizaki, U; Kanaya, K; Okamoto, T; Ono, T; Sakai, S | 1 |
| Baxi, SS; Boucai, L; Dunn, LA; Fagin, JA; Fish, S; Ghossein, RA; Grewal, RK; Haque, S; Ho, AL; Knauf, JA; Larson, SM; Li, D; Ni, A; Pentlow, KS; Pfister, DG; Sabra, MM; Seshan, VE; Sherman, EJ; Tchekmedyian, V; Tuttle, RM; Walters, J | 1 |
| Dehbi, HM; Hackshaw, A; Harmer, C; Mallick, U; Newbold, K; Wadsley, J | 1 |
| Campos, D; González, P; Paillahueque, G; Spuler, J | 1 |
| Campbell, J; Fink-Bennett, D; Wu, D | 1 |
| Bardet, S; Blanchard, D; Ciappuccini, R; de Raucourt, D; Hardouin, J; Heutte, N; Quak, E; Rame, JP; Vaur, D | 1 |
| Calsolari, MR; Rosario, PW; Siman, TL | 1 |
| Dotan, I; Mitmaker, EJ; Paliouras, M; Roche, PJ; Trifiro, MA | 1 |
| Mourão, GF; Rosario, PW | 1 |
| Busemeyer, S; Dietlein, M; Kobe, C; Schicha, H; Schmidt, M; Theissen, P | 1 |
| Gerrard, G; Patel, CN; Prestwich, RJ; Scarsbrook, AF; Viner, S | 1 |
1 trial(s) available for transferrin and Familial Nonmedullary Thyroid Cancer
| Article | Year |
|---|---|
Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial.
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Adolescent; Adult; Aged; Chemoradiotherapy, Adjuvant; Female; Humans; Iodine Radioisotopes; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Radiotherapy Dosage; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; United Kingdom; Young Adult | 2019 |
12 other study(ies) available for transferrin and Familial Nonmedullary Thyroid Cancer
| Article | Year |
|---|---|
Topics: Humans; Iodine Radioisotopes; Radiobiology; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin Alfa; Thyroxine | 2022 |
Response to "Radioiodine Is Molecular Radiotherapy Governed by Predictable Deterministic Radiobiology Expressed in Gray, Not Millicuries" by Kao.
Topics: Humans; Iodine Radioisotopes; Radiobiology; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin Alfa; Thyroxine | 2022 |
Low-dose radioiodine therapy for patients with intermediate- to high-risk differentiated thyroid cancer.
Topics: Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Radiation; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Japan; Male; Middle Aged; Retrospective Studies; Risk Assessment; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Time Factors; Treatment Outcome; Whole Body Imaging | 2020 |
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers.
Topics: Adult; Aged; Cell Dedifferentiation; Cell Differentiation; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Radiation Tolerance; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin Alfa; Vemurafenib | 2019 |
[Intravenous radioiodine and recombinant human TSH in a patient with extensive thyroid cáncer. Report of one case].
Topics: Administration, Intravenous; Aged; Antineoplastic Agents; Gastrostomy; Humans; Iodine Radioisotopes; Male; Radionuclide Imaging; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin Alfa; Thyroxine; Tracheostomy; Treatment Outcome | 2018 |
Thyroid remnant ablation following administration of a diagnostic dose of iodine-131 under thyrogen stimulation.
Topics: Carcinoma; Carcinoma, Papillary; Female; Humans; Hypothyroidism; Iodine Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Postoperative Complications; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Treatment Outcome | 2014 |
Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burden.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Substance Withdrawal Syndrome; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa; Thyroxine; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Triiodothyronine; Tumor Burden | 2014 |
Day 3 thyroglobulin ≤ 1 ng/ml after recombinant human TSH just prior to radioactive iodine is predictive of low risk for persistent/recurrent disease in patients with papillary thyroid carcinoma.
Topics: Ablation Techniques; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Child; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neck; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiography; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin Alfa; Ultrasonography; Whole Body Imaging; Young Adult | 2015 |
Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells.
Topics: Animals; Antibodies, Neoplasm; Carcinoma; Carcinoma, Papillary; Cell Line, Tumor; Drug Delivery Systems; Humans; Low-Level Light Therapy; Nanotubes, Carbon; Neoplasm Proteins; Receptors, Thyrotropin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin Alfa | 2016 |
Is 131I ablation necessary for patients with low-risk papillary thyroid carcinoma and slightly elevated stimulated thyroglobulin after thyroidectomy?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Young Adult | 2016 |
Recombinant human TSH versus hypothyroidism. Cost-minimization-analysis in the follow-up care of differentiated thyroid carcinoma.
Topics: Carcinoma; Carcinoma, Papillary; Fatigue; Female; Hospitalization; Humans; Hypothyroidism; Male; Recombinant Proteins; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa | 2010 |
Increasing the yield of recombinant thyroid-stimulating hormone-stimulated 2-(18-fluoride)-flu-2-deoxy-D-glucose positron emission tomography-CT in patients with differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Recombinant Proteins; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin Alfa; Tomography, X-Ray Computed; Young Adult | 2012 |